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Introduction miR-155 is a typical multifunctional miRNA which is involved in a wide range of different immune and inflammatory processes (Faraoni et al. 2009 ). Inflammation is increasingly recognised as a key mechanism leading to neurodegenerative diseases with an observed upregulation of miR-155 in Parkinson's disease (PD), multiple sclerosis (MS), motor neuron disease (MND), Alzheimer's disease (AD) and other dementias (Butovsky et al. 2015; Caggiu et al. 2018; Chen et al. 2018; Tili et al. 2018 ). In MND, miR-155 is strongly upregulated in the spinal cord of both familial and sporadic MND with dysregulation of previously validated miR-155 downstream targets in the lumbar ventral horn (Butovsky et al. 2015) . Genetic ablation of miR-155 ameliorated disease severity and prolonged survival in SOD1 G93A mice, a widely used rodent model of MND. Furthermore, treating SOD1 G93A mice with anti-miR-155 at the beginning of disease onset also improved the disease phenotype and prolonged the lifespan, suggesting that miR-155 could be a therapeutic target for human MND (Butovsky et al. 2015) .
In post-mortem studies of PD patient brains, activated microglia and increased concentrations of pro-inflammatory cytokines have been identified within the substantia nigra (Boka et al. 1994; McGeer et al. 1988 ). An increase in proinflammatory cytokines in both PD patient serum and cerebrospinal fluid (CSF) has been reported (Dobbs et al. 1999; Mogi et al. 1994) . Distinct cytokine profiles may be associated with more aggressive progression of the disease (Williams-Gray et al. 2016 ). Genetic studies of risk factors for PD and epidemiological studies also support the role of inflammation in PD (Kaur et al. 2017) . miR-155 is significantly upregulated in the substantia nigra pars compacta (SNpc) of mice with adeno-associated-virusmediated expression of alpha-synuclein. This rodent model of PD demonstrated microgliosis and a 30% loss of dopaminergic neurons. In contrast, miR-155 -/-mice
transduced with alpha-synuclein showed attenuated inflammatory responses and near complete neuroprotection (Thome et al. 2016 ).
Heterozygous mutations in GBA1 are the most common risk factor for PD (Gegg and Schapira 2018) whilst bi-allelic GBA1 mutations cause Gaucher's disease (GD), the most common lysosomal storage disorder (Davidson et al. 2018) . A key pathological feature of GD is the infiltration and accumulation of Gaucher cells in many different organs, particularly the haemopoietic system (Baris et al. 2014) . Gaucher cells are infiltrating glycolipid-engorged macrophages and the source of increased inflammatory markers observed in GD patients (Panicker et al. 2014) .
Neuroinflammation is thought to be a major contributing feature to neurodegeneration in GD, as demonstrated by the upregulation of inflammatory markers, astrogliosis, and microglial activation correlating with neurona l loss in two murine models of GD (Farfel-Becker et al. 2011; Massaro et al. 2018; Vitner et al. 2012 ). Microglial activation is therefore a common feature in both PD and GD brains (Ginns et al. 2014) . Of note, plasma levels of monocyte-associated inflammatory markers (including IL8, MCP-1, MIP1α, SCF, and PARC) are increased in GBA1 +/-PD patients and increased IL8 levels were also associated with poorer cognition (Chahine et al. 2013) . This suggests that inflammation may be a particularly important aspect of pathogenic mechanism in GBA-linked PD.
We recently described a gba1 mutant zebrafish line (gba -/-) generated by TALEN mutagenesis which faithfully modelled key aspects of human GD, including Gaucher cell accumulation, neurodegeneration and marked elevation of GD biomarkers. We observed early activation of immune/inflammatory mechanisms with microglial activation and increased miR-155 transcription levels at 4 or 5 days post fertilisation (dpf) respectively. Of note, both the early microglial activation and the accompanying miR-155 activation dramatically preceded the onset of a change in phenotype which
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Compared to the larval stages, we observed a striking inflammatory phenotype at 12 weeks, with a further increase of miR-155 levels and marked microglial accumulation (Keatinge et al. 2015) .
The aim of this study was therefore to investigate whether miR-155 upregulation may be a universal feature of GCase deficiency in mammalian models systems of GD and to determine whether miR-155 ablation may have a neuroprotective effect in gba1 deficiency.
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Methods

Zebrafish husbandry
All larval and adult zebrafish were housed at the University Cas9 protein (NEB). F0 injected embryos were raised to 3 months then crossed to wild type (WT) to identify founders. The progeny of selected F0 founders were then outcrossed to generate the F1 generation where appropriate mutant alleles were identified and selected for further study. The line was genotyped using primers F 5'-TATGACGTCCACATGCATGC and R 5'-GATGTTCAGACGGTTCGCTC.
miR-155
+/-were crossed to gba1 +/-to generate double heterozygous individuals.
These were subsequently in-crossed to generate double mutants. At each in-cross larvae were genotyped at 3dpf by larval tail biopsy as previously described (Wilkinson et al. 2013 ) and each genotype raised in genotype-specific tanks at a ACCEPTED MANUSCRIPT
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density of 10-15 fish per tank. All individuals were re-genotyped at 10 weeks postfertilisation.
Gene expression analyses
RNA was extracted from zebrafish adult brains (12wpf), cortex of 21 day old Gba f lox/f lox ;nestin-Cre and Gba f lox/WT ;nestin-Cre mice, or BV2 microglial cells at specific time points using TRIzol® (Life Technologies™). cDNA was synthesised using a Verso TM reverse transcription kit (Thermo Fisher Scientific). Gene expression was determined using Brilliant II SYBR® Green QPCR Master Mix (Agilent Technologies) on a Stratagene MxPro 3000P (Stratagene) qPCR machine. For all experiments, ef1α was used as a reference gene.
For miRNA qPCR analysis, RNA was extracted as above. For zebrafish and mouse brain RNA the RNA concentration was accurately quantified using the QuantiFluor™ RNA system (Promega) and the Qubit® fluorometer (Life Technologies). 100ng of total RNA was reverse-transcribed and subsequently qPCR was performed using
TaqMan miRNA assays to quantify miR-155 levels. For mouse BV2 microglial cells miRNA was extracted from cells using PureLink miRNA isolation kit (ThermoFisher) and then converted to cDNA using TaqMan miRNA RT Kit (ThermoFisher). TaqMan miRNA assays were used to quantify miR-155 levels, and were normalised against U6 RNA (TaqMan, ThermoFisher).
All primer sequences listed in supplementary information.
Microglial culture and CBE treatment
Mouse BV2 microglial cells were grown in DMEM (4.5 g/L glucose) supplemented with 10% (v/v) fetal calf serum treated with 100 μM CBE for 10 days, with the media changed every 3 days. miR-155 expression was then measured as stated above.
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T IHC to assess microglial invasion of zebrafish brain
Sample preparation for microglial IHC to investigate microglial activation in zebrafish brains was carried out as reported previously (Bai, Parris, and Burton 2014) .
Zebrafish were perfused and brains post-fixed in 4% PFA, followed by cryoprotection in PBS-sucrose. 14µm-thick cryosections were mounted on glass slides, post-fixed, treated with 3% H 2 O 2 in PBS for 5 minutes, then PBS-T (0.3% Triton-X) for 1h, blocked with 10% goat serum in PBS for 2h and then incubated overnight at 4°C with primary antibody (7.4.C4, purified from hybridoma clone; #92092321, HPA Culture
Collections, UK), diluted 1:20 in PBS with 1% goat serum. Primary antibody was detected using a biotinylated anti-mouse antibody (Vector Laboratories, Burlingame, CA, USA) followed by incubation with avidin-biotin-peroxidase complexes and staining using DAB (Vector Laboratories). Images were acquired using an Olympus BX51 compound light microscope. Microglia counts in multiple fields from 3 -4 sections for 4 animals per group were made by an observer blinded to genotype.
Statistical tests and analysis
Graphpad prism V7 software (Graphpad) was used for statistical analysis and all errors bars shown denote standard deviation. All experiments were performed in biological triplicate unless otherwise stated. All data were analysed with either onetailed t-test or two-way ANOVA with Tukey's post-tests.
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Results
GCase deficiency leads to robust increase of miR-155 and downstream inflammatory markers in vitro and in vivo
To determine whether miR-155 was also upregulated in mammalian models of GCase deficiency, we assessed miR-155 expression in the brain of Gba f lox/f lox ;NestinCre mice; a model of neuronal GD (Vitner et al. 2012 ). In this model, miR-155 levels were 6-fold increased (Fig 1A; n=6, p=0 .0004, one-tailed t-test). To complement this data, we also analysed miR-155 expression in mouse BV2 microglial cells treated with the GCase inhibitor conduritol-B-epoxide (CBE) for 10 days. CBE treatment inhibited GCase activity by 90.6% (Control, 214.0  5.3 nmol/h/mg protein; CBE, 20.1  3.2 nmol/h/mg protein) and resulted in a 1.5-fold increase in miR-155 relative to untreated controls (Fig 1B; n=3, p=0 .031, one-tailed t-test). These results confirm that miR-155 upregulation is not limited to gba1 -/-zebrafish but can also be observed in mammalian models of GCase deficiency. To determine whether miR-155 levels were elevated in other zebrafish models of neurodegeneration, we analysed miR-155 levels in the brains of adult pink1 deficient zebrafish (Flinn et al. 2013) . No increase in miR-155 was detected (data not shown).
To confirm a biological effect of increased miR-155 levels, we next determined the expression of its downstream target genes tnfa/tnfb (orthologous to human TNFα) and cxcl8-l1/cxcl8-l2 (orthologous to human IL8) in gba1 -/-zebrafish brains (Lippai et al. 2013; Min et al. 2014; Pathak et al. 2015) . Both IL8 orthologues (cxcl8-l1/cxcl8-l2)
and tnfb were 15-20 fold upregulated in brain tissue from gba1 -/-zebrafish at 12 wpf (Fig 1C; n=3, p<0 .05, two-way ANOVA). TNFα was also previously shown to be highly upregulated in brain tissue of Gba f lox/f lox ;Nestin-Cre mice (Vitner et al. 2012 ).
Generation of a miR-155 knock out line using CRISPR/Cas9
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Having established that miR-155 upregulation is conserved in mammalian genetic and chemically-induced models of GCase deficiency, we next sought to determine whether miR-155 inactivation could be neuroprotective in the context of GCase deficiency. We used CRIPSR/Cas9 technology to generate a stable mutant miR-155 zebrafish line. A mutant with a complex genetic mutation was identified. There is a tandem duplication of the mir-155 gene, one copy carries a 55bp deletion and the other carries a large insertion (253bp) and small 5bp deletion (Fig 2A-B) . miRNAs genes are transcribed by RNA polymerase II, the resultant transcript, usually around 80 nucleotides, adopts a hairpin loop secondary structure called the pri-miRNA. The pri-miRNA is exported to the cytoplasm and cleaved to produce the mature miRNA ( Fig 2C) . The mutation generated in our mutant mi-R155 zebrafish line significantly disrupts the sequence of the miRNA gene; we hypothesised that this would prevent the correct folding of the pri-miRNA and subsequent processing of the mature miRNA. Furthermore, the mature miRNA sequence itself is disrupted by the mutation.
In the first miRNA gene resulting from the duplication only 5bp of the mature miRNA sequence remains; in the second, a large insertion is present in the middle of the mature miRNA sequence. To confirm the deleterious effect of the complex mir-155 mutation, a TaqMan TM MicroRNA Assay was applied. This assay uses a loopedprimer RT-PCR to specifically recognise the mature miRNA sequence. As predicted, this experiment confirmed the complete absence of mature miR-155 in the brain tissue of miR-155 -/-zebrafish ( Fig 2D, n=3, p=0 .0044, one-tailed t-test). 
Genetic ablation of miR-155 does not increase survival or alter inflammatory phenotypes of gba1 -/-zebrafish
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Discussion and Conclusions
There is growing interest in the role of epigenetic mechanisms in neurodegeneration We showed that miR-155 was upregulated in three vertebrate models of GCase deficiency: gba1 -/-zebrafish, Gba f lox/f lox ;Nestin-Cre mice, and mouse BV2 microglia treated with CBE, a GCase inhibitor. We also showed that the orthologues of TNFα and IL-8, inflammatory markers which are regulated by direct targets of miR-155 (Lippai et al. 2013; Min et al. 2014; Pathak et al. 2015) , are also highly upregulated in the brains of gba1 deficient zebrafish. IL-8 was shown to be upregulated in PD patients with GBA mutations (Chahine et al. 2013) and TNFα is upregulated in GD patient serum and in the brain of Gba f lox/f lox ;Nestin-Cre mice (Barak et al. 1999; Vitner et al. 2012 ). These findings demonstrate that the pathogenic processes leading to miR-155 upregulation and inflammation is present in both mouse and zebrafish models of GCase deficiency. may exert a weaker, or have no effect on these targets.
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Although zebrafish are a powerful model for genetic studies and 70% of human genes have at least one clear orthologue, many genes have two orthologues due to a large genome duplication event in the zebrafish genome (Howe et al. 2013) . In many cases it is not clear which gene copy is functional or, where both are, which is most closely related to its human counterpart. Our study provides evidence that the two zebrafish orthologues of TNFα, tnfa and tnfb, function differently. We showed that in brains of 3-month-old gba1 mutant zebrafish tnfb was upregulated 8-fold while tnfa was unchanged, this highlights the importance of investigating both orthologues where they are present.
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